Atlas Trials

ENhancing Outcomes Through Goal Assessment and Generating Engagement in Diabetes Mellitus

Clinical trial NCT02910089 · COMPLETED

Trial details

NCT number
NCT02910089
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetes Mellitus Type 2
Start date
2016-10-20
Primary completion
2017-12-20
Enrollment
1400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.